Ben Jones, vice president, Government Relations & Public Policy, McKesson Specialty Health, discusses the importance of capturing real-world evidence in electronic health records (EHRs) and challenges oncologists face when trying to obtain these data from EHRs.
Ben Jones, vice president, Government Relations & Public Policy, McKesson Specialty Health, discusses the importance of capturing real-world evidence in electronic health records (EHRs) and challenges oncologists face when trying to obtain these data from EHRs.
Transcript
How important is capturing real-world evidence in EHRs for improving the care of patients?
From a policy perspective, as all of these proposals come around, they have 1 central theme, and that is trying to drive towards value. Every policy maker wants to do 2 things: they want to increase coverage and reduce costs. That’s very difficult to do unless you can figure out how to drive efficiency and drive toward value. The only way to drive toward value is to make sure that we’ve got a good handle on patient data, and we see how we’re measuring outcomes. We see what’s working, we see what’s not working. We use all of these tools that we believe are driving value and we capture the data to make sure that’s actually the case. As that drive toward value continues, patient data is going to be very important.
Is this real-world evidence easily accessible currently, or are there challenges oncologists experience when trying to obtain these data from EHRs?
It’s still very difficult. Technology had progressed over the last decade by leaps and bounds. Unfortunately, the more desire there is to catch data, sometimes, often times, that means an increased burden from the provider’s perspective. So, there still is that barrier. I think everybody recognizes the value in data, the need and the necessity to gather data and have data that you can trust, that is fully in-depth enough to be of value down the road. The problem then becomes do we have the right systems in place to make sure that burden is not so much that we’re reducing the value of data down the road?
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
VBID, Heading Into a Third Decade, Looks to Promote Personalization and Access
March 12th 2025Speakers at the 2025 Value-Based Insurance Design summit recapped the accomplishments made over the past 20 years in designing insurance benefits with value in mind and looked ahead to iterations to come.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
Advancing HIV Care With Doravirine and Islatravir: Q&A With Amy Colson, MD, MPH
March 12th 2025New data from the MK-8591A-051 and MK-8591A-052 trials, both investigating the efficacy and safety of 100-mg doravirine and 0.25-mg islatravir as a once-daily 2-drug regimen for virologically suppressed people living with HIV-1, were presented today by Amy Colson, MD, MPH.
Read More
Implementation, Adherence to DoxyPEP Remains Low in At-Risk Groups
March 12th 2025Patients in Washington D.C. and San Francisco had minimal early uptake and adherence to doxycycline post-exposure prophylaxis (DoxyPEP) in studies presented at the Conference on Retroviruses and Opportunistic Infections 2025.
Read More